medigraphic.com
ISSN 1560-4381 (Print)

2019, Number 4

<< Back Next >>

Correo Científico Médico 2019; 23 (4)

Giant pleural mesothelioma. Case presentation

Fiallo CR, Díaz AMT, Gómez LB, Sagué LJL, Doimeadios RZ

Language: Spanish
References: 8
Page:
PDF size: 282.02 Kb.


ABSTRACT

We describe a 50-year-old patient treated, for presenting a general picture and respiratory distress and on chest x-ray a uniform condensation of the three lower fourths of the left lung field with significant deviation of the heart and mediastinum to the right that compresses the right lung significantly, without signs of effusion, operated at La Dolorosa private hospital, Chimborazo province, Ecuador, by Dr. Rodrigo Fiallo Cobos. The computerized axial tomography corroborates a large irregular solid mass, which occupies 90% of the left hemithorax. The histopathological result corresponded with giant benign fibrous tumor (benign mesothelioma) of pleura. After the thoracotomy the patient dies, due to the giant tumor mass and the maintained vital organs involvement.


REFERENCES

  1. Salazar Vargas C. A propósito de mesotelioma pleural. Acta Méd Costarricense. 2006[citado 30 mar 2019]; 48(1):4-4. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022006000100001&lng=en&tlng=es

  2. Sinis SI, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG. Carbon Nanotubes and Other Engineered Nanoparticles Induced Pathophysiology on Mesothelial Cells and Mesothelial Membranes. Front Physiol. 2018[citado 30 mar 2019]; 9: 295. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884948

  3. Maineri Hidalgo JA, Putvinsky V, Mainieri Breedy G. Mesotelioma pleural en Costa Rica. Acta Méd Costarricense. 2006[citado 30 mar 2019];48(1): 24-29. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022006000100005&lng=en&tlng=es

  4. Armas Moredo K, García Rodríguez ME, Acosta Prieto S, Armas Pérez BA. Mesotelioma pleural maligno en ocho pacientes y revisión del tema. Rev Cubana Cir. 2016 [citado 29 mar 2019]; 55 (4): 340-347. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034-74932016000400009&lng=es

  5. Ascoli V, Murer B, Nottegar A, Luchini C, Carella R, Calabrese F, et al. What's new in mesothelioma. Pathologica. 2018[citado 29 mar 2019]; 110(1):12-28. Disponible en: http://www.pathologica.it/article/view/37

  6. Bruno R, Alì G, Fontanini G. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review. J Thorac Dis. 2018[citado 29 mar 2019]; 10 (suppl 2):342-352. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830565

  7. Solbes E, Harper RW. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. J Investig Med. 2018[citado 29 mar 2019]; 66(4):721-727. Disponible en: https://jim.bmj.com/content/66/4/721.long

  8. Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, Tognon MG. New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Front Oncol. 2018[citado 29 mar 2019]; 8: 91. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891579/?report=reader




2020     |     www.medigraphic.com